³í¹®) A single arm phase Ib/II trial offirst-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer ¿¬¼¼¾Ïº´¿ø Á¾¾ç³»°ú ¶ó¼±¿µ·Á¤¹Î±Ô·±èÈ¿¼Û·ÀÌÃæ±Ù ±³¼ö, ¿¬¼¼´ë Á¤Çöö ¸í¿¹±³¼ö